Related Experiment Video
Updated: Nov 8, 2025
08:11
Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
Published on: August 25, 2017
11.8K
Adeno-Associated Virus Vector for Central Nervous System Gene Therapy
Danqing Zhu1, Adam J Schieferecke2, Paola A Lopez3
1California Institute for Quantitative Biosciences, University of California, Berkeley, CA, 94720, USA.
Trends in Molecular Medicine
|April 25, 2021
Summary
Gene therapy using adeno-associated virus (AAV) vectors shows promise for neurological disorders by delivering replacement genes and utilizing gene editing tools. Ongoing research focuses on improving AAV engineering and cargo design for safer, more effective delivery.
Area of Science:
- Neurology
- Genetics
- Biotechnology
Background:
- Significant advances in therapeutic gene delivery for central nervous system (CNS) neurological disorders.
- Genome-wide sequencing has improved understanding of monogenic disorders, aiding clinical progress.
- Adeno-associated virus (AAV) vector delivery of replacement genes is a key strategy for recessive disorders.
Purpose of the Study:
- To discuss advances in adeno-associated virus (AAV) engineering for gene therapy.
- To review recent developments in gene therapy cargo design.
- To explore the translation of these technologies towards clinical progress in treating neurological disorders.
Main Methods:
- Review of AAV engineering advancements.
- Analysis of novel gene therapy cargo designs.
- Discussion of clinical translation strategies for gene delivery technologies.
Main Results:
- Progress in AAV vector development for enhanced gene delivery.
- Innovations in designing therapeutic gene cargoes.
- Identification of challenges in delivery and safety for CNS gene therapies.
Conclusions:
- AAV engineering and cargo design are crucial for advancing gene therapy.
- Despite progress, challenges in delivery and safety must be addressed for clinical success.
- Continued research is vital for translating gene therapy technologies to treat neurological disorders effectively.
